{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:55:24Z","timestamp":1777640124834,"version":"3.51.4"},"reference-count":145,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDM"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pancreatic cancer is a highly lethal malignancy with a low 5-year survival rate. This review focuses\non natural compounds as potential therapeutics for it. Different types of natural compounds, such as\npolyphenols, saponins, and alkaloids, have shown anti-pancreatic cancer effects, including inhibiting tumor\ncell growth, inducing apoptosis, and preventing angiogenesis. They also have indirect impacts on pancreatic\ncancer through influencing the gut microbiota, glucose and lipid metabolism, and the endocrine system. Additionally,\nChinese herbal medicines containing these compounds show promise in clinical applications.\nHowever, challenges such as target identification and low bioavailability persist. Future research trends involve\ninterdisciplinary collaboration and the use of advanced technologies to overcome these issues.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892002393013250812093213","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:53:46Z","timestamp":1759312426000},"page":"225-239","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Natural Compounds as Potential Therapeutics for Pancreatic Cancer: A Narrative Review"],"prefix":"10.2174","volume":"26","author":[{"given":"Xing-Da","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Pancreatic-Biliary Surgery, The First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Integrative Medicine of Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin 300100, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Xia","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Central Hospital of Shenyang Medical College, Shenyang 110024, Liaoning Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-Chen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pancreatic-Biliary Surgery, The First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pancreatic-Biliary Surgery, The First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1025618","DOI":"10.3389\/fphar.2022.1025618","volume":"13","author":"Zhao J.F.","year":"2022","unstructured":"Zhao J.F.; Zou F.L.; Zhu J.F.; Huang C.; Bu F.Q.; Zhu Z.M.; Yuan R.F.; Nano-drug delivery system for pancreatic cancer: A visualization and bibliometric analysis. Front Pharmacol  2022,13,1025618","journal-title":"Front Pharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00432-024-05644-2","volume":"150","author":"Ren L.","year":"2024","unstructured":"Ren L.; Lu R.; Fei X.; Chen S.; Liu P.; Zhu C.; Wang X.; Pan Y.; Unveiling the role of PYGB in pancreatic cancer: A novel diagnostic biomarker and gene therapy target. J Cancer Res Clin Oncol  2024,150(3),127","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"122844","DOI":"10.1016\/j.ijpharm.2023.122844","volume":"636","author":"Zhao Y.","year":"2023","unstructured":"Zhao Y.; Zheng Y.; Zhu Y.; Ding K.; Zhou M.; Liu T.; Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer. Int J Pharm  2023,636,122844","journal-title":"Int J Pharm"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"101143","DOI":"10.1016\/j.neo.2025.101143","volume":"62","author":"Steen T.V.","year":"2025","unstructured":"Steen T.V.; Espinoza I.; Duran C.; Casadevall G.; Serrano-Herv\u00e1s E.; Cuy\u00e0s E.; Verdura S.; Kemble G.; Kaufmann S.H.; McWilliams R.; Osuna S.; Billadeau D.D.; Menendez J.A.; Lupu R.; Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer. Neoplasia  2025,62,101143","journal-title":"Neoplasia"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.3390\/cancers14133152","volume":"14","author":"Yang H.","year":"2022","unstructured":"Yang H.; Liu B.; Liu D.; Yang Z.; Zhang S.; Xu P.; Xing Y.; Kutschick I.; Pfeffer S.; Britzen-Laurent N.; Gr\u00fctzmann R.; Pilarsky C.; Genome-wide crispr screening identifies DCK and CCNL1 as genes that contribute to gemcitabine resistance in pancreatic cancer. Cancers  2022,14(13),3152","journal-title":"Cancers"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"18162","DOI":"10.18632\/oncotarget.4216","volume":"6","author":"Wang J.P.","year":"2015","unstructured":"Wang J.P.; Wu C.Y.; Yeh Y.C.; Shyr Y.M.; Wu Y.Y.; Kuo C.Y.; Hung Y.P.; Chen M.H.; Lee W.P.; Luo J.C.; Chao Y.; Li C.P.; Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: A randomized, open-label, prospective trial. Oncotarget  2015,6(20),18162-18173","journal-title":"Oncotarget"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.3390\/cimb45030164","volume":"45","author":"Ferguson R.","year":"2023","unstructured":"Ferguson R.; Aughton K.; Evans A.; Shaw V.; Armstrong J.; Ware A.; Bennett L.; Costello E.; Greenhalf W.; Mutant K-Ras in pancreatic cancer: An insight on the role of wild-type N-Ras and K-Ras-dependent cell cycle regulation. Curr Issues Mol Biol  2023,45(3),2505-2520","journal-title":"Curr Issues Mol Biol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3390\/biomedicines12061168","volume":"12","author":"Jaroszewski B.","year":"2024","unstructured":"Jaroszewski B.; Jelonek K.; Kasperczyk J.; Drug delivery systems of betulin and its derivatives: An overview. Biomedicines  2024,12(6),1168","journal-title":"Biomedicines"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/antiox13010071","volume":"13","author":"Kostecka-Guga\u0142a A.","year":"2024","unstructured":"Kostecka-Guga\u0142a A.; Quinces (Cydonia oblonga, Chaenomeles sp., and Pseudocydonia sinensis) as Medicinal Fruits of the Rosaceae Family: Current State of Knowledge on Properties and Use. Antioxidants  2024,13(1),71","journal-title":"Antioxidants"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.3390\/pharmaceutics14122593","volume":"14","author":"Braciuliene A.","year":"2022","unstructured":"Braciuliene A.; Janulis V.; Petrikaite V.; The chemo-sensitizing effect of doxorubicin of apple extract-enriched triterpenic complex on human colon adenocarcinoma and human glioblastoma cell lines. Pharmaceutics  2022,14(12),2593","journal-title":"Pharmaceutics"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/nu14071505","volume":"14","author":"Mudhish E.A.","year":"2022","unstructured":"Mudhish E.A.; Siddique A.B.; Ebrahim H.Y.; Abdelwahed K.S.; King J.A.; El Sayed K.A.; The tobacco \u03b2-cembrenediol: A prostate cancer recurrence suppressor lead and prospective scaffold via modulation of indoleamine 2,3-dioxygenase and tryptophan dioxygenase. Nutrients  2022,14(7),1505","journal-title":"Nutrients"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.3390\/ijms23074038","volume":"23","author":"Arora P.","year":"2022","unstructured":"Arora P.; Li W.; Huang X.; Yu W.; Huang R.; Jiang Q.; Chen C.; Metabolic reconfiguration activates stemness and immunomodulation of PDLSCs. Int J Mol Sci  2022,23(7),4038","journal-title":"Int J Mol Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1250918","DOI":"10.3389\/fphar.2024.1250918","volume":"15","author":"Yang K.","year":"2024","unstructured":"Yang K.; Zeng L.; He Q.; Wang S.; Xu H.; Ge J.; Advancements in research on the immune-inflammatory mechanisms mediated by NLRP3 inflammasome in ischemic stroke and the regulatory role of natural plant products. Front Pharmacol  2024,15,1250918","journal-title":"Front Pharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.3390\/foods12173262","volume":"12","author":"Garza-Ju\u00e1rez A.","year":"2023","unstructured":"Garza-Ju\u00e1rez A.; P\u00e9rez-Carrillo E.; Arredondo-Espinoza E.U.; Islas J.F.; Ben\u00edtez-Chao D.F.; Escamilla-Garc\u00eda E.; Nutraceuticals and their contribution to preventing noncommunicable diseases. Foods  2023,12(17),3262","journal-title":"Foods"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.3390\/nu14194128","volume":"14","author":"Zhang J.","year":"2022","unstructured":"Zhang J.; Zhang H.; Xin X.; Zhu Y.; Ye Y.; Li D.; Efficacy of flavonoids on animal models of polycystic ovary syndrome: A systematic review and meta-analysis. Nutrients  2022,14(19),4128","journal-title":"Nutrients"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/foods10010106","volume":"10","author":"Pinto T.","year":"2021","unstructured":"Pinto T.; Aires A.; Cosme F.; Bacelar E.; Morais M.C.; Oliveira I.; Ferreira-Cardoso J.; Anjos R.; Vilela A.; Gon\u00e7alves B.; Bioactive (Poly)phenols, volatile compounds from vegetables, medicinal and aromatic plants. Foods  2021,10(1),106","journal-title":"Foods"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"841639","DOI":"10.3389\/fgene.2022.841639","volume":"13","author":"Laka K.","year":"2022","unstructured":"Laka K.; Makgoo L.; Mbita Z.; Cholesterol-lowering phytochemicals: Targeting the mevalonate pathway for anticancer interventions. Front Genet  2022,13,841639","journal-title":"Front Genet"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"102145","DOI":"10.1016\/j.cis.2020.102145","volume":"279","author":"G\u00f3ral I.","year":"2020","unstructured":"G\u00f3ral I.; Wojciechowski K.; Surface activity and foaming properties of saponin-rich plants extracts. Adv Colloid Interface Sci  2020,279,102145","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.3390\/cancers12113399","volume":"12","author":"G\u00f3mez de Cedr\u00f3n M.","year":"2020","unstructured":"G\u00f3mez de Cedr\u00f3n M.; Navarro del Hierro J.; Reguero M.; Wagner S.; Bouzas A.; Quijada-Freire A.; Reglero G.; Mart\u00edn D.; Ram\u00edrez de Molina A.; Saponin-rich extracts and their acid hydrolysates differentially target colorectal cancer metabolism in the frame of precision nutrition. Cancers  2020,12(11),3399","journal-title":"Cancers"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/725023","volume":"2015","author":"Yu Z.","year":"2015","unstructured":"Yu Z.; Zhang T.; Zhou F.; Xiao X.; Ding X.; He H.; Rang J.; Quan M.; Wang T.; Zuo M.; Xia L.; Anticancer activity of saponins from Allium chinense against the B16 Melanoma and 4T1 Breast Carcinoma Cell. Evid Based Complement Alternat Med  2015,2015,1-12","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3390\/antibiotics10091142","volume":"10","author":"Guimar\u00e3es R.","year":"2021","unstructured":"Guimar\u00e3es R.; Milho C.; Liberal \u00c2.; Silva J.; Fonseca C.; Barbosa A.; Ferreira I.C.F.R.; Alves M.J.; Barros L.; Antibiofilm potential of medicinal plants against Candida spp. Oral biofilms: A review. Antibiotics  2021,10(9),1142","journal-title":"Antibiotics"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1080\/14786410802267692","volume":"23","author":"Kumar P.","year":"2009","unstructured":"Kumar P.; Sharma B.; Bakshi N.; Biological activity of alkaloids from Solanum dulcamara L. Nat Prod Res  2009,23(8),719-723","journal-title":"Nat Prod Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.3390\/ijms25063521","volume":"25","author":"Andr\u00e9s C.M.C.","year":"2024","unstructured":"Andr\u00e9s C.M.C.; P\u00e9rez de la Lastra J.M.; Bustamante Munguira E.; Juan C.A.; Plou F.J.; P\u00e9rez Lebe\u00f1a E.; Electrophilic compounds in the human diet and their role in the induction of the transcription factor NRF2. Int J Mol Sci  2024,25(6),3521","journal-title":"Int J Mol Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"6830","DOI":"10.1002\/fsn3.3666","volume":"11","author":"Zhao X.","year":"2023","unstructured":"Zhao X.; Yan F.; Li X.S.; Qu D.; Xu Y.L.; A systematic review of tea pigments: Prevention of major diseases, protection of organs, and potential mechanisms and applications. Food Sci Nutr  2023,11(11),6830-6844","journal-title":"Food Sci Nutr"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/ph16081074","volume":"16","author":"Aiassa V.","year":"2023","unstructured":"Aiassa V.; Garnero C.; Zoppi A.; Longhi M.R.; Cyclodextrins and their derivatives as drug stability modifiers. Pharmaceuticals  2023,16(8),1074","journal-title":"Pharmaceuticals"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1039\/D2NP00008C","volume":"39","author":"Roddan R.","year":"2022","unstructured":"Roddan R.; Carter E.M.; Thair B.; Hailes H.C.; Chemoenzymatic approaches to plant natural product inspired compounds. Nat Prod Rep  2022,39(7),1375-1382","journal-title":"Nat Prod Rep"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3390\/plants11111410","volume":"11","author":"Guan Y.","year":"2022","unstructured":"Guan Y.; Chen S.; Chen F.; Chen F.; Jiang Y.; Exploring the relationship between trichome and terpene chemistry in chrysanthemum. Plants  2022,11(11),1410","journal-title":"Plants"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/molecules26020499","volume":"26","author":"Shah M.D.","year":"2021","unstructured":"Shah M.D.; Tani K.; Yong Y.S.; Ching F.F.; Shaleh S.R.M.; Vairappan C.S.; Venmathi Maran B.A.; Antiparasitic potential of chromatographic fractions of Nephrolepis biserrata and liquid chromatography-quadrupole time-of-flight-mass spectrometry analysis. Molecules  2021,26(2),499","journal-title":"Molecules"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/genes12091380","volume":"12","author":"Al-Harbi L.N.","year":"2021","unstructured":"Al-Harbi L.N.; Pandurangan S.B.; Al-Dossari A.M.; Shamlan G.; Salamatullah A.M.; Alshatwi A.A.; Alotiby A.A.; Beta vulgaris rubra L. (Beetroot) peel methanol extract reduces oxidative stress and stimulates cell proliferation via increasing vegf expression in H2O2 induced oxidative stressed human umbilical vein endothelial cells. Genes  2021,12(9),1380","journal-title":"Genes"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.2147\/DDDT.S464910","volume":"18","author":"Gu X.","year":"2024","unstructured":"Gu X.; Zhou H.; Miao M.; Hu D.; Wang X.; Zhou J.; Teichmann A.T.; Yang Y.; Wang C.; Therapeutic potential of natural resources against endometriosis: Current advances and future perspectives. Drug Des Devel Ther  2024,18,3667-3696","journal-title":"Drug Des Devel Ther"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5005\/jp-journals-10005-1660","volume":"12","author":"Tripathi A.M.","year":"2019","unstructured":"Tripathi A.M.; Devi M.T.; Kalra S.K.; Ghoshal U.; Kalra S.K.; Ghoshal U.; Evaluation of the antimicrobial efficacy of herbal extracts added to root canal sealers of different bases: An in vitro study. Int J Clin Pediatr Dent  2019,12(5),398-404","journal-title":"Int J Clin Pediatr Dent"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/molecules28031336","volume":"28","author":"Rizkiyah D.N.","year":"2023","unstructured":"Rizkiyah D.N.; Putra N.R.; Yunus M.A.C.; Veza I.; Irianto I.; Aziz A.H.A.; Rahayuningsih S.; Yuniarti E.; Ikhwani I.; Insight into green extraction for roselle as a source of natural red pigments: A review. Molecules  2023,28(3),1336","journal-title":"Molecules"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3390\/plants11141885","volume":"11","author":"Kitic D.","year":"2022","unstructured":"Kitic D.; Miladinovic B.; Randjelovic M.; Szopa A.; Sharifi-Rad J.; Calina D.; Seidel V.; Anticancer potential and other pharmacological properties of Prunus armeniaca L.: An updated overview. Plants  2022,11(14),1885","journal-title":"Plants"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.3390\/molecules26216560","volume":"26","author":"Ratajczak K.","year":"2021","unstructured":"Ratajczak K.; Glatzel-Pluci\u0144ska N.; Ratajczak-Wielgomas K.; Nowi\u0144ska K.; Borska S.; Effect of resveratrol treatment on human pancreatic cancer cells through alterations of Bcl-2 family members. Molecules  2021,26(21),6560","journal-title":"Molecules"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1159\/000333542","volume":"11","author":"Mo W.","year":"2011","unstructured":"Mo W.; Xu X.; Xu L.; Wang F.; Ke A.; Wang X.; Guo C.; Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell. Pancreatology  2011,11(6),601-609","journal-title":"Pancreatology"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"112126","DOI":"10.1016\/j.yexcr.2020.112126","volume":"394","author":"Srivani G.","year":"2020","unstructured":"Srivani G.; Behera S.K.; Dariya B.; Aliya S.; Alam A.; Nagaraju G.P.; Resveratrol binds and inhibits transcription factor HIF-1\u03b1 in pancreatic cancer. Exp Cell Res  2020,394(1),112126","journal-title":"Exp Cell Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"16530","DOI":"10.1371\/journal.pone.0016530","volume":"6","author":"Shankar S.","year":"2011","unstructured":"Shankar S.; Nall D.; Tang S.N.; Meeker D.; Passarini J.; Sharma J.; Srivastava R.K.; Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One  2011,6(1),16530","journal-title":"PLoS One"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3892\/or.2016.4930","volume":"36","author":"Borska S.","year":"2016","unstructured":"Borska S.; Pedziwiatr M.; Danielewicz M.; Nowinska K.; Pula B.; Drag-Zalesinska M.; Olbromski M.; Gomulkiewicz A.; Dziegiel P.; Classical and atypical resistance of cancer cells as a target for resveratrol. Oncol Rep  2016,36(3),1562-1568","journal-title":"Oncol Rep"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1053\/j.gastro.2023.02.025","volume":"164","author":"Jiang X.","year":"2023","unstructured":"Jiang X.; Ma Y.; Wang T.; Zhou H.; Wang K.; Shi W.; Qin L.; Guan J.; Li L.; Long B.; Wang J.; Guan X.; Ye H.; Yang J.; Yu Z.; Jiao Z.; Targeting UBE2T potentiates gemcitabine efficacy in pancreatic cancer by regulating pyrimidine metabolism and replication stress. Gastroenterology  2023,164(7),1232-1247","journal-title":"Gastroenterology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"155392","DOI":"10.1016\/j.phymed.2024.155392","volume":"127","author":"Xu M.","year":"2024","unstructured":"Xu M.; Zhong W.; Yang C.; Liu M.; Yuan X.; Lu T.; Li D.; Zhang G.; Liu H.; Zeng Y.; Yang X.; Zhou Y.; Zhou L.; Tiliroside disrupted iron homeostasis and induced ferroptosis via directly targeting calpain-2 in pancreatic cancer cells. Phytomedicine  2024,127,155392","journal-title":"Phytomedicine"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12935-022-02677-w","volume":"22","author":"Asgharian P.","year":"2022","unstructured":"Asgharian P.; Tazekand A.P.; Hosseini K.; Forouhandeh H.; Ghasemnejad T.; Ranjbar M.; Hasan M.; Kumar M.; Beirami S.M.; Tarhriz V.; Soofiyani S.R.; Kozhamzharova L.; Sharifi-Rad J.; Calina D.; Cho W.C.; Potential mechanisms of quercetin in cancer prevention: Focus on cellular and molecular targets. Cancer Cell Int  2022,22(1),257","journal-title":"Cancer Cell Int"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3390\/nu11081856","volume":"11","author":"Wei R.","year":"2019","unstructured":"Wei R.; Cortez Penso N.E.; Hackman R.M.; Wang Y.; Mackenzie G.G.; Epigallocatechin-3-gallate (EGCG) suppresses pancreatic cancer cell growth, invasion, and migration partly through the inhibition of AKT pathway and epithelial\u2013mesenchymal transition: Enhanced efficacy when combined with gemcitabine. Nutrients  2019,11(8),1856","journal-title":"Nutrients"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1142\/S0192415X23500362","volume":"51","author":"Hu L.","year":"2023","unstructured":"Hu L.; Xu X.; Chen X.; Qiu S.; Li Q.; Zhang D.; Wang F.; Epigallocatechin-3-gallate decreases hypoxia-inducible factor-1 in pancreatic cancer cells. Am J Chin Med  2023,51(3),761-777","journal-title":"Am J Chin Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.31661\/gmj.v11i.2248","volume":"11","author":"Sanaei M.","year":"2022","unstructured":"Sanaei M.; Kavoosi F.; Poursadgh Soufiani I.; Effect of sodium butyrate and epigallocatechin-3-gallate on the genes expression of intrinsic apoptotic pathway on PA-TU-8902, CFPAC-1, and CAPAN-1 human pancreatic cancer cell lines: Epi-drugs and intrinsic apoptotic pathway in pancreatic cancer. Galen Med J  2022,11,2248","journal-title":"Galen Med J"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1097\/00006676-200405000-00020","volume":"28","author":"Li Y.","year":"2004","unstructured":"Li Y.; Ellis K.L.; Ali S.; El-Rayes B.F.; Nedeljkovic-Kurepa A.; Kucuk O.; Philip P.A.; Sarkar F.H.; Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. Pancreas  2004,28(4),e90-e95","journal-title":"Pancreas"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"9064","DOI":"10.1158\/0008-5472.CAN-05-1330","volume":"65","author":"Banerjee S.","year":"2005","unstructured":"Banerjee S.; Zhang Y.; Ali S.; Bhuiyan M.; Wang Z.; Chiao P.J.; Philip P.A.; Abbruzzese J.; Sarkar F.H.; Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res  2005,65(19),9064-9072","journal-title":"Cancer Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1038\/s41388-018-0390-1","volume":"37","author":"Ferro R.","year":"2018","unstructured":"Ferro R.; Adamska A.; Lattanzio R.; Mavrommati I.; Edling C.E.; Arifin S.A.; Fyffe C.A.; Sala G.; Sacchetto L.; Chiorino G.; De Laurenzi V.; Piantelli M.; Sansom O.J.; Maffucci T.; Falasca M.; GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. Oncogene  2018,37(49),6368-6382","journal-title":"Oncogene"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"998346","DOI":"10.3389\/fonc.2022.998346","volume":"12","author":"Farhan M.","year":"2022","unstructured":"Farhan M.; Rizvi A.; Ali F.; Ahmad A.; Aatif M.; Malik A.; Alam M.W.; Muteeb G.; Ahmad S.; Noor A.; Siddiqui F.A.; Pomegranate juice anthocyanidins induce cell death in human cancer cells by mobilizing intracellular copper ions and producing reactive oxygen species. Front Oncol  2022,12,998346","journal-title":"Front Oncol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1068855","DOI":"10.3389\/fphar.2022.1068855","volume":"13","author":"Zhang T.","year":"2022","unstructured":"Zhang T.; Liu M.; Liu Q.; Xiao G.G.; Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway. Front Pharmacol  2022,13,1068855","journal-title":"Front Pharmacol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41419-019-1366-y","volume":"10","author":"Jia S.","year":"2019","unstructured":"Jia S.; Xu X.; Zhou S.; Chen Y.; Ding G.; Cao L.; Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways. Cell Death Dis  2019,10(2),142","journal-title":"Cell Death Dis"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"50956","DOI":"10.1371\/journal.pone.0050956","volume":"7","author":"Lou C.","year":"2012","unstructured":"Lou C.; Zhang F.; Yang M.; Zhao J.; Zeng W.; Fang X.; Zhang Y.; Zhang C.; Liang W.; Naringenin decreases invasiveness and metastasis by inhibiting TGF-\u03b2-induced epithelial to mesenchymal transition in pancreatic cancer cells. PLoS One  2012,7(12),50956","journal-title":"PLoS One"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fct.2016.11.008","volume":"99","author":"Park H.J.","year":"2017","unstructured":"Park H.J.; Choi Y.J.; Lee J.H.; Nam M.J.; Naringenin causes ASK1-induced apoptosis via reactive oxygen species in human pancreatic cancer cells. Food Chem Toxicol  2017,99,1-8","journal-title":"Food Chem Toxicol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"120752","DOI":"10.1016\/j.lfs.2022.120752","volume":"305","author":"Motallebi M.","year":"2022","unstructured":"Motallebi M.; Bhia M.; Rajani H.F.; Bhia I.; Tabarraei H.; Mohammadkhani N.; Pereira-Silva M.; Kasaii M.S.; Nouri-Majd S.; Mueller A.L.; Veiga F.J.B.; Paiva-Santos A.C.; Shakibaei M.; Naringenin: A potential flavonoid phytochemical for cancer therapy. Life Sci  2022,305,120752","journal-title":"Life Sci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1393409","DOI":"10.3389\/fphar.2024.1393409","volume":"15","author":"Ma Y.","year":"2024","unstructured":"Ma Y.; Zhao Y.; Luo M.; Jiang Q.; Liu S.; Jia Q.; Bai Z.; Wu F.; Xie J.; Advancements and challenges in pharmacokinetic and pharmacodynamic research on the traditional Chinese medicine saponins: A comprehensive review. Front Pharmacol  2024,15,1393409","journal-title":"Front Pharmacol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3390\/ijms25042340","volume":"25","author":"Palanisamy R.","year":"2024","unstructured":"Palanisamy R.; Indrajith Kahingalage N.; Archibald D.; Casari I.; Falasca M.; Synergistic anticancer activity of plumbagin and xanthohumol combination on pancreatic cancer models. Int J Mol Sci  2024,25(4),2340","journal-title":"Int J Mol Sci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/biom10020221","volume":"10","author":"Abotaleb M.","year":"2020","unstructured":"Abotaleb M.; Liskova A.; Kubatka P.; B\u00fcsselberg D.; Therapeutic potential of plant phenolic acids in the treatment of cancer. Biomolecules  2020,10(2),221","journal-title":"Biomolecules"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.3390\/ma13245813","volume":"13","author":"Zaremba-Czogalla M.","year":"2020","unstructured":"Zaremba-Czogalla M.; Jaromin A.; Sidoryk K.; Zag\u00f3rska A.; Cybulski M.; Gubernator J.; Evaluation of the in vitro cytotoxic activity of caffeic acid derivatives and liposomal formulation against pancreatic cancer cell lines. Materials  2020,13(24),5813","journal-title":"Materials"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2024.2318481","volume":"\u2022","author":"Gupta S.","year":"2024","unstructured":"Gupta S.; Tak H.; Rathore K.; Banavath H.N.; Tejavath K.K.; Caffeic acid, a dietary polyphenol, pre-sensitizes pancreatic ductal adenocarcinoma to chemotherapeutic drug. J Biomol Struct Dyn  2024,\u2022,1-15","journal-title":"J Biomol Struct Dyn"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.3892\/or.2017.5516","volume":"37","author":"Duan J.","year":"2017","unstructured":"Duan J.; Xiaokaiti Y.; Fan S.; Pan Y.; Li X.; Li X.; Direct interaction between caffeic acid phenethyl ester and human neutrophil elastase inhibits the growth and migration of PANC-1 cells. Oncol Rep  2017,37(5),3019-3025","journal-title":"Oncol Rep"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/1574892818666230327134746","volume":"19","author":"Chen X.","year":"2024","unstructured":"Chen X.; Liu B.; Tong J.; Bo J.; Feng M.; Yin L.; Lin X.; Chlorogenic acid inhibits proliferation, migration and invasion of pancreatic cancer cells via AKT\/GSK-3\u03b2\/\u03b2-catenin signaling pathway. Recent Patents Anticancer Drug Discov  2024,19(2),146-153","journal-title":"Recent Patents Anticancer Drug Discov"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tiv.2016.12.001","volume":"40","author":"Brecht K.","year":"2017","unstructured":"Brecht K.; Riebel V.; Couttet P.; Paech F.; Wolf A.; Chibout S.D.; Pognan F.; Kr\u00e4henb\u00fchl S.; Uteng M.; Mechanistic insights into selective killing of OXPHOS-dependent cancer cells by arctigenin. Toxicol In Vitro  2017,40,55-65","journal-title":"Toxicol In Vitro"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/md20080473","volume":"20","author":"Lee W.","year":"2022","unstructured":"Lee W.; Song G.; Bae H.; Matairesinol induces mitochondrial dysfunction and exerts synergistic anticancer effects with 5-fluorouracil in pancreatic cancer cells. Mar Drugs  2022,20(8),473","journal-title":"Mar Drugs"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"21573","DOI":"10.1371\/journal.pone.0021573","volume":"6","author":"Arora S.","year":"2011","unstructured":"Arora S.; Bhardwaj A.; Srivastava S.K.; Singh S.; McClellan S.; Wang B.; Singh A.P.; Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PLoS One  2011,6(6),21573","journal-title":"PLoS One"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/molecules21060730","volume":"21","author":"Zhao X.","year":"2016","unstructured":"Zhao X.; Tao X.; Xu L.; Yin L.; Qi Y.; Xu Y.; Han X.; Peng J.; Dioscin induces apoptosis in human cervical carcinoma hela and SIHA cells through ros-mediated dna damage and the mitochondrial signaling pathway. Molecules  2016,21(6),730","journal-title":"Molecules"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3892\/or.2013.2517","volume":"30","author":"Son M.K.","year":"2013","unstructured":"Son M.K.; Jung K.H.; Lee H.S.; Lee H.; Kim S.J.; Yan H.H.; Ryu Y.L.; Hong S.S.; SB365, Pulsatilla saponin D suppresses proliferation and induces apoptosis of pancreatic cancer cells. Oncol Rep  2013,30(2),801-808","journal-title":"Oncol Rep"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jss.2014.01.026","volume":"188","author":"Liu Q.","year":"2014","unstructured":"Liu Q.; Chen W.; Jiao Y.; Hou J.; Wu Q.; Liu Y.; Qi X.; Pulsatilla saponin A, an active molecule from Pulsatilla chinensis, induces cancer cell death and inhibits tumor growth in mouse xenograft models. J Surg Res  2014,188(2),387-395","journal-title":"J Surg Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00432-012-1152-z","volume":"138","author":"Wang Y.W.","year":"2012","unstructured":"Wang Y.W.; Wang S.J.; Zhou Y.N.; Pan S.H.; Sun B.; Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-\u03baB and nuclear factor-\u03baB-regulated gene products in pancreatic cancer both in vitro and in vivo. J Cancer Res Clin Oncol  2012,138(5),785-797","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/bph.13718","volume":"174","author":"Si L.","year":"2017","unstructured":"Si L.; Xu L.; Yin L.; Qi Y.; Han X.; Xu Y.; Zhao Y.; Liu K.; Peng J.; Potent effects of dioscin against pancreatic cancer via miR\u2010149\u20103P\u2010mediated inhibition of the Akt1 signalling pathway. Br J Pharmacol  2017,174(7),553-568","journal-title":"Br J Pharmacol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/2211-5463.12457","volume":"8","author":"MarElia C.B.","year":"2018","unstructured":"MarElia C.B.; Sharp A.E.; Shemwell T.A.; Clare Zhang Y.; Burkhardt B.R.; Anemarrhena asphodeloides Bunge and its constituent timosaponin\u2010 AIII induce cell cycle arrest and apoptosis in pancreatic cancer cells. FEBS Open Bio  2018,8(7),1155-1166","journal-title":"FEBS Open Bio"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1002\/jbt.22480","volume":"34","author":"Zou J.","year":"2020","unstructured":"Zou J.; Su H.; Zou C.; Liang X.; Fei Z.; Ginsenoside Rg3 suppresses the growth of gemcitabine\u2010resistant pancreatic cancer cells by upregulating lncRNA\u2010CASC2 and activating PTEN signaling. J Biochem Mol Toxicol  2020,34(6),22480","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=71","first-page":"1418","volume":"45","author":"Xiao M.F.","year":"2020","unstructured":"Xiao M.F.; [Effect of polyphyllin D on proliferation and apoptosis of human pancreatic cancer cells]. Zhongguo Zhongyao Zazhi  2020,45(6),1418-1422","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.2174\/1871520620999201110191459","volume":"21","author":"Yao L.C.","year":"2021","unstructured":"Yao L.C.; Wu L.; Wang W.; Zhai L.L.; Ye L.; Xiang F.; Tang Z.G.; Panax notoginseng saponins promote cell death and chemosensitivity in pancreatic cancer through the apoptosis and autophagy pathways. Anticancer Agents Med Chem  2021,21(13),1680-1688","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"15347354211006191","DOI":"10.1177\/15347354211006191","volume":"20","author":"Jang H.J.","year":"2021","unstructured":"Jang H.J.; Yang J.H.; Hong E.; Jo E.; Lee S.; Lee S.; Choi J.S.; Yoo H.S.; Kang H.; Chelidonine induces apoptosis via GADD45a-p53 regulation in human pancreatic cancer cells. Integr Cancer Ther  2021,20,15347354211006191","journal-title":"Integr Cancer Ther"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbrc.2023.06.062","volume":"673","author":"Liu Y.","year":"2023","unstructured":"Liu Y.; Zhang W.; Zhou H.; Chen J.; Steroidal saponins PPI\/CCRIS\/PSV induce cell death in pancreatic cancer cell through GSDME-dependent pyroptosis. Biochem Biophys Res Commun  2023,673,51-58","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S1875-5364(21)60033-X","volume":"19","author":"Zhong Y.","year":"2021","unstructured":"Zhong Y.; Li X.Y.; Zhou F.; Cai Y.J.; Sun R.; Liu R.P.; Ziyuglycoside II inhibits the growth of digestive system cancer cells through multiple mechanisms. Chin J Nat Med  2021,19(5),351-363","journal-title":"Chin J Nat Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/molecules29010113","volume":"29","author":"Shen L.","year":"2023","unstructured":"Shen L.; Luo H.; Fan L.; Tian X.; Tang A.; Wu X.; Dong K.; Su Z.; Potential immunoregulatory mechanism of plant saponins: A review. Molecules  2023,29(1),113","journal-title":"Molecules"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"110579","DOI":"10.1016\/j.intimp.2023.110579","volume":"122","author":"Xu X.","year":"2023","unstructured":"Xu X.; Cui L.; Zhang L.; Yang L.; Zhuo Y.; Li C.; Saikosaponin d modulates the polarization of tumor-associated macrophages by deactivating the PI3K\/AKT\/mTOR pathway in murine models of pancreatic cancer. Int Immunopharmacol  2023,122,110579","journal-title":"Int Immunopharmacol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4103\/0973-1296.165548","volume":"11","author":"Zhong L.","year":"2015","unstructured":"Zhong L.; Zhou Z.; Zhang C.; Fei H.; Bai Y.; Phenolic alkaloids from Menispermum dauricum inhibits BxPC-3 pancreatic cancer cells by blocking of Hedgehog signaling pathway. Pharmacogn Mag  2015,11(44),690-697","journal-title":"Pharmacogn Mag"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/cas.13847","volume":"110","author":"Ishii N.","year":"2019","unstructured":"Ishii N.; Araki K.; Yokobori T.; Hagiwara K.; Gantumur D.; Yamanaka T.; Handa T.; Tsukagoshi M.; Igarashi T.; Watanabe A.; Kubo N.; Harimoto N.; Masamune A.; Umezawa K.; Kuwano H.; Shirabe K.; Conophylline suppresses pancreatic cancer desmoplasia and cancer\u2010promoting cytokines produced by cancer\u2010associated fibroblasts. Cancer Sci  2019,110(1),334-344","journal-title":"Cancer Sci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"155377","DOI":"10.1016\/j.phymed.2024.155377","volume":"128","author":"Zhu S.L.","year":"2024","unstructured":"Zhu S.L.; Qi M.; Chen M.T.; Lin J.P.; Huang H.F.; Deng L.J.; Zhou X.W.; A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer. Phytomedicine  2024,128,155377","journal-title":"Phytomedicine"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1021\/acs.jnatprod.8b00733","volume":"81","author":"Awale S.","year":"2018","unstructured":"Awale S.; Dibwe D.F.; Balachandran C.; Fayez S.; Feineis D.; Lombe B.K.; Bringmann G.; Ancistrolikokine E 3, a 5,8\u2032-coupled naphthylisoquinoline alkaloid, eliminates the tolerance of cancer cells to nutrition starvation by inhibition of the Akt\/mTOR\/Autophagy signaling pathway. J Nat Prod  2018,81(10),2282-2291","journal-title":"J Nat Prod"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"107408","DOI":"10.1016\/j.isci.2023.107408","volume":"26","author":"Mukherjee D.","year":"2023","unstructured":"Mukherjee D.; Chakraborty S.; Bercz L.; D\u2019Alesio L.; Wedig J.; Torok M.A.; Pfau T.; Lathrop H.; Jasani S.; Guenther A.; McGue J.; Adu-Ampratwum D.; Fuchs J.R.; Frankel T.L.; Pietrzak M.; Culp S.; Strohecker A.M.; Skardal A.; Mace T.A.; Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progression. iScience  2023,26(8),107408","journal-title":"iScience"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13045-022-01350-z","volume":"15","author":"Qin R.","year":"2022","unstructured":"Qin R.; You F.M.; Zhao Q.; Xie X.; Peng C.; Zhan G.; Han B.; Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: From molecular mechanisms to potential therapeutic targets. J Hematol Oncol  2022,15(1),133","journal-title":"J Hematol Oncol"},{"key":"ref=84","first-page":"2350","volume":"7","author":"Li F.","year":"2017","unstructured":"Li F.; Jiang T.; Li Q.; Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: Did we miss something in CPT analogue molecular targets for treating human disease such as cancer? Am J Cancer Res  2017,7,2350-2394","journal-title":"Am J Cancer Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"16888","DOI":"10.1021\/acs.jmedchem.3c01589","volume":"66","author":"Wang W.","year":"2023","unstructured":"Wang W.; Ling X.; Wang R.; Xiong H.; Hu L.; Yang Z.; Wang H.; Zhang Y.; Wu W.; Singh P.K.; Wang J.; Li F.; Li Q.; Structure\u2013activity relationship of fl118 platform position 7 versus position 9-derived compounds and their mechanism of action and antitumor activity. J Med Chem  2023,66(24),16888-16916","journal-title":"J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pan.2012.11.305","volume":"13","author":"Yagublu V.","year":"2013","unstructured":"Yagublu V.; Caliskan N.; Lewis A.L.; Jesenofsky R.; Gasimova L.; L\u00f6hr J.M.; Keese M.; Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinotecan-drug eluting beads. Pancreatology  2013,13(1),79-87","journal-title":"Pancreatology"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3892\/or.2011.1257","volume":"26","author":"Liu A.","year":"2011","unstructured":"Liu A.; Chen H.; Wei W.; Ye S.; Liao W.; Gong J.; Jiang Z.; Wang L.; Lin S.; Antiproliferative and antimetastatic effects of emodin on human pancreatic cancer. Oncol Rep  PMID:214910882011,26(1),81-89","journal-title":"Oncol Rep"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.3892\/mmr.2015.4158","volume":"12","author":"Lin S.Z.","year":"2015","unstructured":"Lin S.Z.; Xu J.B.; Ji X.; Chen H.; Xu H.T.; Hu P.; Chen L.; Guo J.Q.; Chen M.Y.; Lu D.; Wang Z.H.; Tong H.F.; Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-\u03b2\/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs. Mol Med Rep  2015,12(4),5865-5871","journal-title":"Mol Med Rep"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3892\/ijo.2011.1147","volume":"39","author":"Wei W.T.","year":"2011","unstructured":"Wei W.T.; Chen H.; Ni Z.L.; Liu H.B.; Tong H.F.; Fan L.; Liu A.; Qiu M.X.; Liu D.L.; Guo H.C.; Wang Z.H.; Lin S.Z.; Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation. Int J Oncol  PMID: 218050322011,39(6),1381-1390","journal-title":"Int J Oncol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/1568009623666230328123915","volume":"23","author":"Huang W.","year":"2023","unstructured":"Huang W.; Dai Y.; Xu L.; Mao Y.; Huang Z.; Ji X.; Dihydrotanshinone I.; Dihydrotanshinone I inhibits pancreatic cancer progression via Hedgehog\/gli signal pathway. Curr Cancer Drug Targets  2023,23(9),731-741","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"969550","DOI":"10.3389\/fphar.2022.969550","volume":"13","author":"Li C.","year":"2022","unstructured":"Li C.; Xie J.; Wang J.; Cao Y.; Pu M.; Gong Q.; Lu Q.; Therapeutic effects and mechanisms of plant-derived natural compounds against intestinal mucositis. Front Pharmacol  2022,13,969550","journal-title":"Front Pharmacol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3892\/ijo.2022.5398","volume":"61","author":"Terado T.","year":"2022","unstructured":"Terado T.; Kim C.; Ushio A.; Minami K.; Tambe Y.; Kageyama S.; Kawauchi A.; Tsunoda T.; Shirasawa S.; Tanaka H.; Inoue H.; Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS activated pancreatic cancer cells. Int J Oncol  2022,61(3),108","journal-title":"Int J Oncol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.7150\/ijbs.70567","volume":"18","author":"Xu Z.","year":"2022","unstructured":"Xu Z.; Hou Y.; Zou C.; Liang H.; Mu J.; Jiao X.; Zhu Y.; Su L.; Liu M.; Chen X.; Qian C.; Zhu X.; Gong W.; Dong Q.; Zhang F.; Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-\u03baB activation. Int J Biol Sci  2022,18(7),2759-2774","journal-title":"Int J Biol Sci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.3390\/pharmaceutics15122651","volume":"15","author":"Shah V.M.","year":"2023","unstructured":"Shah V.M.; Rizvi S.; Smith A.; Tsuda M.; Krieger M.; Pelz C.; MacPherson K.; Eng J.; Chin K.; Munks M.W.; Daniel C.J.; Al-Fatease A.; Yardimci G.G.; Langer E.M.; Brody J.R.; Sheppard B.C.; Alani A.W.G.; Sears R.C.; Micelle-formulated juglone effectively targets pancreatic cancer and remodels the tumor microenvironment. Pharmaceutics  2023,15(12),2651","journal-title":"Pharmaceutics"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4149\/BLL_2021_020","volume":"122","author":"Gokturk F.","year":"2021","unstructured":"Gokturk F.; Erkoc-Kaya D.; Arikoglu H.; Juglone can inhibit angiogenesis and metastasis in pancreatic cancer cells by targeting Wnt\/\u03b2-catenin signaling. Bratisl Med J  2021,122(2),132-137","journal-title":"Bratisl Med J"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"104788","DOI":"10.1016\/j.tiv.2020.104788","volume":"65","author":"Pandey K.","year":"2020","unstructured":"Pandey K.; Tripathi S.K.; Panda M.; Biswal B.K.; Prooxidative activity of plumbagin induces apoptosis in human pancreatic ductal adenocarcinoma cells via intrinsic apoptotic pathway. Toxicol In Vitro  2020,65,104788","journal-title":"Toxicol In Vitro"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.12659\/MSM.917240","volume":"25","author":"Pan Q.","year":"2019","unstructured":"Pan Q.; Zhou R.; Su M.; Li R.; The effects of plumbagin on pancreatic cancer: A mechanistic network pharmacology approach. Med Sci Monit  2019,25,4648-4654","journal-title":"Med Sci Monit"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1092020","DOI":"10.3389\/fonc.2022.1092020","volume":"12","author":"Zhao Z.","year":"2023","unstructured":"Zhao Z.; Liu L.; Li S.; Hou X.; Yang J.; Advances in research on the relationship between thymoquinone and pancreatic cancer. Front Oncol  2023,12,1092020","journal-title":"Front Oncol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"8054","DOI":"10.1021\/acs.jmedchem.3c00394","volume":"66","author":"Awale S.","year":"2023","unstructured":"Awale S.; Baba H.; Phan N.D.; Kim M.J.; Maneenet J.; Sawaki K.; Kanda M.; Okumura T.; Fujii T.; Okada T.; Maruyama T.; Okada T.; Toyooka N.; Targeting pancreatic cancer with novel plumbagin derivatives: Design, synthesis, molecular mechanism, in vitro and in vivo evaluation. J Med Chem  2023,66(12),8054-8065","journal-title":"J Med Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"113575","DOI":"10.1016\/j.biopha.2022.113575","volume":"154","author":"Wang Y.","year":"2022","unstructured":"Wang Y.; Feng W.; Wang X.; Li X.; Mou Y.; Wang X.; Zhang Y.; The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art. Biomed Pharmacother  2022,154,113575","journal-title":"Biomed Pharmacother"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/cancers15030715","volume":"15","author":"Bhuyan P.P.","year":"2023","unstructured":"Bhuyan P.P.; Nayak R.; Patra S.; Abdulabbas H.S.; Jena M.; Pradhan B.; Seaweed-derived sulfated polysaccharides; the new age chemopreventives: A comprehensive review. Cancers  2023,15(3),715","journal-title":"Cancers"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"113228","DOI":"10.1016\/j.phytochem.2022.113228","volume":"200","author":"Ma L.M.","year":"2022","unstructured":"Ma L.M.; Wang K.; Meng X.H.; Zheng Y.D.; Wang C.B.; Chai T.; Naghavi M.R.; Sang C.Y.; Yang J.L.; Terpenoids from Nardostachys jatamansi and their cytotoxic activity against human pancreatic cancer cell lines. Phytochemistry  2022,200,113228","journal-title":"Phytochemistry"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12906-019-2544-2","volume":"19","author":"Long J.","year":"2019","unstructured":"Long J.; Liu Z.; Hui L.; Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma. BMC Complement Altern Med  2019,19(1),133","journal-title":"BMC Complement Altern Med"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"15277","DOI":"10.1002\/cam4.6170","volume":"12","author":"Wang H.","year":"2023","unstructured":"Wang H.; Liu Y.; Wang Y.; Xu T.; Xia G.; Huang X.; Umbelliprenin induces autophagy and apoptosis while inhibits cancer cell stemness in pancreatic cancer cells. Cancer Med  2023,12(14),15277-15288","journal-title":"Cancer Med"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijbiomac.2020.06.054","volume":"162","author":"Bian Y.","year":"2020","unstructured":"Bian Y.; Zeng H.; Tao H.; Huang L.; Du Z.; Wang J.; Ding K.; A pectin-like polysaccharide from Polygala tenuifolia inhibits pancreatic cancer cell growth in vitro and in vivo by inducing apoptosis and suppressing autophagy. Int J Biol Macromol  2020,162,107-115","journal-title":"Int J Biol Macromol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.1039\/D0FO00403K","volume":"11","author":"Tao H.","year":"2020","unstructured":"Tao H.; Chen X.; Du Z.; Ding K.; Corn silk crude polysaccharide exerts anti-pancreatic cancer activity by blocking the EGFR\/PI3K\/AKT\/CREB signaling pathway. Food Funct  2020,11(8),6961-6970","journal-title":"Food Funct"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"131891","DOI":"10.1016\/j.ijbiomac.2024.131891","volume":"268","author":"Ding M.","year":"2024","unstructured":"Ding M.; Yang Y.; Zhang Z.; Liu H.; Dai Y.; Wang Z.; Ma S.; Liu Y.; Wang Q.; Structural characterization of the polysaccharide from the black crystal region of Inonotus obliquus and its effect on AsPC-1 and SW1990 pancreatic cancer cell apoptosis. Int J Biol Macromol  2024,268(Pt 2),131891","journal-title":"Int J Biol Macromol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.carbpol.2018.10.008","volume":"204","author":"Yao Y.","year":"2019","unstructured":"Yao Y.; Zhou L.; Liao W.; Chen H.; Du Z.; Shao C.; Wang P.; Ding K.; HH1-1, a novel Galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking Galectin-3\/EGFR\/AKT\/FOXO3 signaling pathway. Carbohydr Polym  2019,204,111-123","journal-title":"Carbohydr Polym"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/onc.2016.306","volume":"36","author":"Zhang L.","year":"2017","unstructured":"Zhang L.; Wang P.; Qin Y.; Cong Q.; Shao C.; Du Z.; Ni X.; Li P.; Ding K.; RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivovia blocking galectin-3 associated signaling pathways. Oncogene  2017,36(9),1297-1308","journal-title":"Oncogene"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s44160-023-00428-x","volume":"3","author":"Qin X.","year":"2023","unstructured":"Qin X.; Xu C.; Liu M.; Zeng F.; Yao W.; Deng Y.; Xu T.; Sun S.; Sun D.; Mo J.; Ye X.S.; Synthesis of branched arabinogalactans up to a 140-mer from Panax notoginseng and their anti-pancreatic-cancer activity. Nature Synthesis  2023,3(2),245-255","journal-title":"Nature Synthesis"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"105658","DOI":"10.1016\/j.phrs.2021.105658","volume":"169","author":"Zhang P.","year":"2021","unstructured":"Zhang P.; Tao W.; Lu C.; Fan L.; Jiang Q.; Yang C.; Shang E.; Cheng H.; Che C.; Duan J.; Zhao M.; Bruceine A induces cell growth inhibition and apoptosis through PFKFB4\/GSK3\u03b2 signaling in pancreatic cancer. Pharmacol Res  2021,169,105658","journal-title":"Pharmacol Res"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.7150\/ijbs.91832","volume":"20","author":"Huang Y.","year":"2024","unstructured":"Huang Y.; Zhang R.; Lyu H.; Xiao S.; Guo D.; Chen X.Z.; Zhou C.; Tang J.; LncRNAs as nodes for the cross-talk between autophagy and Wnt signaling in pancreatic cancer drug resistance. Int J Biol Sci  2024,20(7),2698-2726","journal-title":"Int J Biol Sci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1038\/s41467-024-54963-y","volume":"15","author":"Wu B.","year":"2024","unstructured":"Wu B.; Wang Z.; Liu J.; Li N.; Wang X.; Bai H.; Wang C.; Shi J.; Zhang S.; Song J.; Li Y.; Nie G.; Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine. Nat Commun  2024,15(1),10526","journal-title":"Nat Commun"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"15965","DOI":"10.1038\/ncomms15965","volume":"8","author":"Biancur D.E.","year":"2017","unstructured":"Biancur D.E.; Paulo J.A.; Ma\u0142achowska B.; Quiles Del Rey M.; Sousa C.M.; Wang X.; Sohn A.S.W.; Chu G.C.; Gygi S.P.; Harper J.W.; Fendler W.; Mancias J.D.; Kimmelman A.C.; Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism. Nat Commun  2017,8(1),15965","journal-title":"Nat Commun"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"102206","DOI":"10.1016\/j.tranon.2024.102206","volume":"51","author":"Yao Z.","year":"2025","unstructured":"Yao Z.; Zhang H.; Huang K.; Huang G.; Xi P.; Jiang L.; Qin D.; Chen F.; Li S.; Wei R.; Niraparib perturbs autophagosome-lysosome fusion in pancreatic ductal adenocarcinoma and exhibits anticancer potential against gemcitabine-resistant PDAC. Transl Oncol  2025,51,102206","journal-title":"Transl Oncol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/cancers9110157","volume":"9","author":"Amrutkar M.","year":"2017","unstructured":"Amrutkar M.; Gladhaug I.; Pancreatic cancer chemoresistance to gemcitabine. Cancers  2017,9(11),157","journal-title":"Cancers"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/cells10030497","volume":"10","author":"Fu Y.","year":"2021","unstructured":"Fu Y.; Ricciardiello F.; Yang G.; Qiu J.; Huang H.; Xiao J.; Cao Z.; Zhao F.; Liu Y.; Luo W.; Chen G.; You L.; Chiaradonna F.; Zheng L.; Zhang T.; The role of mitochondria in the chemoresistance of pancreatic cancer cells. Cells  2021,10(3),497","journal-title":"Cells"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.3390\/ijms24087238","volume":"24","author":"Vergara-G\u00f3mez L.","year":"2023","unstructured":"Vergara-G\u00f3mez L.; Bizama C.; Zhong J.; Buchegger K.; Su\u00e1rez F.; Rosa L.; Ili C.; Weber H.; Obreque J.; Espinoza K.; Repetto G.; Roa J.C.; Leal P.; Garc\u00eda P.; A novel gemcitabine-resistant gallbladder cancer model provides insights into molecular changes occurring during acquired resistance. Int J Mol Sci  2023,24(8),7238","journal-title":"Int J Mol Sci"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","volume":"23","author":"Mullen N.J.","year":"2023","unstructured":"Mullen N.J.; Singh P.K.; Nucleotide metabolism: A pan-cancer metabolic dependency. Nat Rev Cancer  2023,23(5),275-294","journal-title":"Nat Rev Cancer"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3892\/mmr.2017.6182","volume":"15","author":"Chen S.","year":"2017","unstructured":"Chen S.; Wang Y.; Zhang W.L.; Dong M.S.; Zhang J.H.; Sclareolide enhances gemcitabine-induced cell death through mediating the NICD and Gli1 pathways in gemcitabine-resistant human pancreatic cancer. Mol Med Rep  2017,15(4),1461-1470","journal-title":"Mol Med Rep"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.3748\/wjg.v25.i15.1797","volume":"25","author":"Rozengurt E.","year":"2019","unstructured":"Rozengurt E.; Eibl G.; Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development. World J Gastroenterol  2019,25(15),1797-1816","journal-title":"World J Gastroenterol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1021\/acs.jproteome.0c00394","volume":"19","author":"Liu J.","year":"2020","unstructured":"Liu J.; Luo X.; Guo R.; Jing W.; Lu H.; Cell metabolomics reveals berberine-inhibited pancreatic cancer cell viability and metastasis by regulating citrate metabolism. J Proteome Res  2020,19(9),3825-3836","journal-title":"J Proteome Res"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"9482018","DOI":"10.1155\/2018\/9482018","volume":"2018","author":"Cheng L.","year":"2018","unstructured":"Cheng L.; Yan B.; Chen K.; Jiang Z.; Zhou C.; Cao J.; Qian W.; Li J.; Sun L.; Ma J.; Ma Q.; Sha H.; Resveratrol\u2010induced downregulation of naf\u20101 enhances the sensitivity of pancreatic cancer cells to gemcitabine via the ROS\/Nrf2 signaling pathways. Oxid Med Cell Longev  2018,2018(1),9482018","journal-title":"Oxid Med Cell Longev"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"860209","DOI":"10.3389\/fphar.2022.860209","volume":"13","author":"Mirazimi S.M.A.","year":"2022","unstructured":"Mirazimi S.M.A.; Dashti F.; Tobeiha M.; Shahini A.; Jafari R.; Khoddami M.; Sheida A.H.; EsnaAshari, P.; Aflatoonian, A.H.; Elikaii, F.; Zakeri, M.S.; Hamblin, M.R.; Aghajani, M.; Bavarsadkarimi, M.; Mirzaei, H. Application of quercetin in the treatment of gastrointestinal cancers. Front Pharmacol  2022,13,860209","journal-title":"Front Pharmacol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.biomaterials.2019.04.005","volume":"208","author":"Khan S.","year":"2019","unstructured":"Khan S.; Setua S.; Kumari S.; Dan N.; Massey A.; Hafeez B.B.; Yallapu M.M.; Stiles Z.E.; Alabkaa A.; Yue J.; Ganju A.; Behrman S.; Jaggi M.; Chauhan S.C.; Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. Biomaterials  2019,208,83-97","journal-title":"Biomaterials"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41388-024-03092-3","volume":"43","author":"Ma M.J.","year":"2024","unstructured":"Ma M.J.; Shi Y.H.; Liu Z.D.; Zhu Y.Q.; Zhao G.Y.; Ye J.Y.; Li F.X.; Huang X.T.; Wang X.Y.; Wang J.Q.; Xu Q.C.; Yin X.Y.; N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance. Oncogene  2024,43(31),2405-2420","journal-title":"Oncogene"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fonc.2020.00163","volume":"10","author":"Cheng H.","year":"2020","unstructured":"Cheng H.; Wang Z.; Cui L.; Wen Y.; Chen X.; Gong F.; Yi H.; Opportunities and challenges of the human microbiome in ovarian cancer. Front Oncol  2020,10,163","journal-title":"Front Oncol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.3390\/nu13124425","volume":"13","author":"Sobocki B.K.","year":"2021","unstructured":"Sobocki B.K.; Ka\u017amierczak-Siedlecka K.; Folwarski M.; Hawry\u0142kowicz V.; Makarewicz W.; Stachowska E.; Pancreatic cancer and gut microbiome-related aspects: A comprehensive review and dietary recommendations. Nutrients  2021,13(12),4425","journal-title":"Nutrients"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1186\/s12885-023-11557-z","volume":"23","author":"Zhu Z.","year":"2023","unstructured":"Zhu Z.; Yi B.; Tang Z.; Chen X.; Li M.; Xu T.; Zhao Z.; Tang C.; Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis. BMC Cancer  2023,23(1),1044","journal-title":"BMC Cancer"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/6069403","volume":"2022","author":"Han Z.","year":"2022","unstructured":"Han Z.; Zhang H.; Lu L.; Li X.; Zhang C.; Zhu J.; Li C.; Wang Q.; Chen K.; Research progress in intestinal microecology in pancreatic cancer diagnosis and treatment. J Oncol  2022,2022,1-10","journal-title":"J Oncol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/ph16010101","volume":"16","author":"Jia W.","year":"2023","unstructured":"Jia W.; Zhou L.; Li L.; Zhou P.; Shen Z.; Nano-based drug delivery of polyphenolic compounds for cancer treatment: Progress, opportunities, and challenges. Pharmaceuticals  2023,16(1),101","journal-title":"Pharmaceuticals"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/pathogens13090801","volume":"13","author":"Lim X.","year":"2024","unstructured":"Lim X.; Ooi L.; Ding U.; Wu H.H.L.; Chinnadurai R.; Gut microbiota in patients receiving dialysis: A review. Pathogens  2024,13(9),801","journal-title":"Pathogens"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/cac2.12204","volume":"41","author":"Yang J.","year":"2021","unstructured":"Yang J.; Xu R.; Wang C.; Qiu J.; Ren B.; You L.; Early screening and diagnosis strategies of pancreatic cancer: A comprehensive review. Cancer Commun  2021,41(12),1257-1274","journal-title":"Cancer Commun"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3390\/ani10091714","volume":"10","author":"Shabbir H.","year":"2020","unstructured":"Shabbir H.; Kausar T.; Noreen S.; Rehman H.U.; Hussain A.; Huang Q.; Gani A.; Su S.; Nawaz A.; In vivo screening and antidiabetic potential of polyphenol extracts from guava pulp, seeds and leaves. Animals  2020,10(9),1714","journal-title":"Animals"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.1097\/JS9.0000000000001555","volume":"110","author":"Yuan Q.","year":"2024","unstructured":"Yuan Q.; Shang D.; \u2018Inflammatory biomarkers and nanotechnology: New insights in pancreatic cancer early detection\u2019. Int J Surg  2024,110(8),5280-5281","journal-title":"Int J Surg"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"110945","DOI":"10.1016\/j.foodres.2022.110945","volume":"153","author":"Zhang Y.","year":"2022","unstructured":"Zhang Y.; Xu Y.; Zhang L.; Chen Y.; Wu T.; Liu R.; Sui W.; Zhu Q.; Zhang M.; Licorice extract ameliorates hyperglycemia through reshaping gut microbiota structure and inhibiting TLR4\/NF-\u03baB signaling pathway in type 2 diabetic mice. Food Res Int  2022,153,110945","journal-title":"Food Res Int"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/plants13071021","volume":"13","author":"Zolotova D.","year":"2024","unstructured":"Zolotova D.; Teterovska R.; Bandere D.; Lauberte L.; Niedra S.; Antidiabetic properties of the root extracts of dandelion (Taraxacum officinale) and Burdock (Arctium lappa). Plants  2024,13(7),1021","journal-title":"Plants"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.3390\/molecules28186653","volume":"28","author":"Skoczylas J.","year":"2023","unstructured":"Skoczylas J.; J\u0119drszczyk E.; Dziadek K.; Dacewicz E.; Kope\u0107 A.; Basic chemical composition, antioxidant activity and selected polyphenolic compounds profile in garlic leaves and bulbs collected at various stages of development. Molecules  2023,28(18),6653","journal-title":"Molecules"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"134591","DOI":"10.1016\/j.foodchem.2022.134591","volume":"404","author":"Wen J.J.","year":"2023","unstructured":"Wen J.J.; Li M.Z.; Chen C.H.; Hong T.; Yang J.R.; Huang X.J.; Geng F.; Hu J.L.; Nie S.P.; Tea polyphenol and epigallocatechin gallate ameliorate hyperlipidemia via regulating liver metabolism and remodeling gut microbiota. Food Chem  2023,404(Pt A),134591","journal-title":"Food Chem"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.3892\/mmr.2015.3340","volume":"11","author":"Ren L.","year":"2015","unstructured":"Ren L.; Guo X.; Shao X.; Li H.; Yao H.; Endocrine gland-derived vascular endothelial growth factor modulates proliferation, apoptosis and migration in pancreatic cancer cells. Mol Med Rep  2015,11(6),4279-4284","journal-title":"Mol Med Rep"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"215","DOI":"10.12717\/DR.2017.21.2.215","volume":"21","author":"Choi D.","year":"2017","unstructured":"Choi D.; Lee S.J.; Lee M.H.; Lee D.K.; Bitter melon seed extract does not alter photoperiodic effects on reproduction of male golden hamsters. Dev Reprod  2017,21(2),215-221","journal-title":"Dev Reprod"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1158\/1055-9965.EPI-22-0518","volume":"32","author":"Jang Y.C.","year":"2023","unstructured":"Jang Y.C.; Leung C.Y.; Huang H.L.; Association of menopausal hormone therapy with risk of pancreatic cancer: A systematic review and meta-analysis of cohort studies. Cancer Epidemiol Biomarkers Prev  2023,32(1),114-122","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.3390\/molecules27206973","volume":"27","author":"Kobylka P.","year":"2022","unstructured":"Kobylka P.; Kucinska M.; Kujawski J.; Lazewski D.; Wierzchowski M.; Murias M.; Resveratrol analogues as selective estrogen signaling pathway modulators: Structure\u2013activity relationship. Molecules  2022,27(20),6973","journal-title":"Molecules"},{"key":"ref=144","first-page":"403","volume":"9","author":"Saif M.W.","year":"2008","unstructured":"Saif M.W.; Is there a role for herbal medicine in the treatment of pancreatic cancer? Highlights from the \u201c44th ASCO Annual Meeting\u201d. Chicago, IL, USA. May 30 - June 3, 2008. JOP  2008,9(4),403-407","journal-title":"JOP"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"828450","DOI":"10.3389\/fonc.2022.828450","volume":"12","author":"Hu J.","year":"2022","unstructured":"Hu J.; Jiang J.; Liu R.; Cheng M.; Zhu G.; He S.; Shi B.; Zhao Y.; He Z.; Yu H.; Zhang X.; Zheng H.; Hua B.; Clinical efficacy and safety of traditional medicine preparations combined with chemotherapy for advanced pancreatic cancer: A systematic review and meta-analysis. Front Oncol  2022,12,828450","journal-title":"Front Oncol"}],"container-title":["Current Drug Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892002393013250812093213","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/245682\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892002393013250812093213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T15:14:46Z","timestamp":1768230886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/245682\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":145,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892002393013250812093213","relation":{},"ISSN":["1389-2002"],"issn-type":[{"value":"1389-2002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}